Clinical Trials Logo

Clinical Trial Summary

To confirm 1) whether, compared with core decompression alone, core decompression with porous tantalum rod implantation improves the hip joint function of patients with avascular necrosis of the femoral head after femoral neck fracture surgery, 2) whether porous tantalum rod shows favorable biocompatibility with the human body, and 3) whether this treatment method is feasible for treating avascular necrosis of the femoral head after femoral neck fracture surgery.


Clinical Trial Description

History and current status of related studies: Femoral neck fracture can render the blood supply to the femoral head insufficient, leading to avascular necrosis of the femoral head. This often increases treatment difficulty and can have a strong influence on the recovery of hip joint function. Although core decompression for treatment of avascular necrosis of the femoral head has been largely used in clinical settings, the mid-term therapeutic effects are not satisfactory in some patients.

Biocompatibility is defined as the ability of a biomaterial, prosthesis, or medical device to perform with an appropriate host response. The biocompatibility of a bone implant and host influences the therapeutic effects. Therefore, biomaterials that are less likely to induce negative host responses may increase the therapeutic effects of such treatments for orthopedic diseases. A porous tantalum rod is a bone trabecula-like metal implant that is used to support weight-bearing areas of necrotic bone, preventing further collapse of the necrotic area. This implant has exhibited favorable effects in the early treatment of avascular necrosis of the femoral head. Although previous reports have focused on porous tantalum rod implantation for clinical treatment of avascular necrosis of the femoral head after fermoral neck fracture, few have assessed the long-term therapeutic effects or biocompatibility of porous tantalum rods.

Adverse events Possible adverse events include any expected or unexpected symptoms. If severe adverse events occur, information including the date of occurrence and measures taken related to the treatment of the adverse events will be reported to the principal investigator and the institutional review board within 24 hours.

Data collection, management, analysis, and open access Data collection: Case report forms with demographic data, disease diagnosis, accompanying diseases, drug allergy history, and adverse events will be collected , processed using Epidata software, collated, and then electrically recorded using a double-data entry strategy by data managers.

Data management: The locked electronic database will not be altered in any way, and will only be available to the project manager. Paper and electronic data regarding screening, informed consent, and clinical outcomes will be preserved at the Affiliated Hospital of Nantong University, China.

Data analysis: The electronic database will be made available to a professional statistician for statistical analysis. An outcome analysis report will be made by the statistician and submitted to the lead researchers. An independent data monitoring committee will supervise and manage the trial data with the goal of ensuring a scientific and stringent trial process, resulting in accurate and complete data.

Data open access: Anonymized trial data will be published at http://www.figshare.com.

Statistical analysis Statistical analysis will be performed by a statistician using SPSS 19.0 software and will follow the intention-to-treat principle. Normally distributed measurement data will be expressed as a mean, standard deviation, min, and max. Non-normally distributed measurement data will be expressed as a lower quartile (q1), median, and upper quartile (q3). McNemar's test will be used to compare the percentage of patients with excellent hip joint function as per Harris hip scores 12 months after surgery, the percentage of patients presenting with femoral head collapse, prosthesis loosening, peri-prosthesis infection, and incidence of complications 6 and 12 months after surgery. The Mann-Whitney U test will be used to compare the VAS score prior to and 1, 6, and 12 months after surgery. Statistical significance will be accepted when α = 0.05. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02877472
Study type Interventional
Source Qinghai University
Contact Heling Zhang, Master
Phone 8613997262938
Email helingzhang_qu@sina.com
Status Recruiting
Phase N/A
Start date May 2015
Completion date May 2017

See also
  Status Clinical Trial Phase
Completed NCT02422355 - A Focused Registry on the Femoral Neck System (FNS) in Patients With Femoral Neck Fractures
Withdrawn NCT02202122 - Interest of the OSA (Obstructive Sleep Apnea) Predictive Scores in the Prognosis of Postoperative Mortality of Femoral Neck Fractures N/A
Terminated NCT01219062 - Postoperative Pain Control After Hip Hemiarthroplasty: Intrathecal Morphine vs Periarticular Infiltration of Bupivacaine Phase 4
Active, not recruiting NCT02362971 - External Validity of a Randomized Trial in Patients With a Femoral Neck Fracture N/A
Completed NCT02591342 - Comparison of a Cemented, Polished Tapered Stem and an Anatomic Stem for Femoral Neck Fracture N/A
Recruiting NCT05171140 - Influence of the Spatial Distribution of Hollow Screws on the Blood Supply and Prognosis of Femoral Neck Fractures N/A
Completed NCT02433548 - Fascia Iliaca Block in the Emergency Department for Analgesia After Femoral Neck Fracture Phase 4
Active, not recruiting NCT03357445 - AVANTAGE® RELOAD Double Mobility Acetabular Cup -Clinical Study N/A
Recruiting NCT03550079 - Fixation for the Treatment of Femoral Neck Fractures N/A
Completed NCT04879472 - Early Functional Outcome of Operative Treatment of Displaced Femoral Neck Fractures in Two Kenyan Orthopaedic Centres
Completed NCT00913679 - A Comparison of Two Different Surgical Techniques in Hip Resurfacing Arthroplasty N/A
Recruiting NCT01112436 - The Effect of Periarticular Multi-Drug Regimen on Pain After Partial Hip Replacement Phase 4
Completed NCT01052974 - Perioperative Analgesia by Femoral Perineural Catheter for Femoral Neck Fracture - Study KTcol Phase 4
Terminated NCT02030431 - Dynaloc for Treatment of Femoral Neck Fractures N/A
Completed NCT01114646 - Functional Status, Morbidity and Mortality in Cemented Versus Press-Fit Hemiarthroplasty N/A
Completed NCT02512094 - Validity and Reliability of Thai Version of Barthel Index for Hip Fracture Patients N/A
Recruiting NCT02148848 - Short-term Functional Recovery Between Early- and Late Bisphosphonate Treatment Following Hemiarthroplasty Phase 4
Completed NCT01644227 - Dual Mobility Cup in Total Hip Arthroplasty Preventing Dislocation in Patients at Risk N/A
Active, not recruiting NCT02901938 - Feasibility of Implantation of Cemented Femoral Stem for Osteoporotic Femoral Neck Fracture in Elderly Patients N/A
Completed NCT02771639 - Early Periprosthetic Joint Infection and Outcome Debridement, Antibiotics and Implant Retention N/A